Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina - On-treatment analysis of the TIME trial

European Heart Journal

Volumn 25, Issue 12, 2004, Pages 1036-1042

  Kaiser, Christoph ^a   Kuster, Gabriela M ^a   Erne, Paul ^b   Amann, Wolfgang ^c   Naegeli, Barbara ^d   Osswald, Stefan ^a   Buser, Peter ^a   Schläpfer, Heinz ^e   Brett, Wolfgang ^a   Zerkowski, Hans Reinhard ^a   Schindler, Christian ^f   Pfisterer, Matthias ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e KANTONSSPITAL   (Switzerland)

^f SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Aging; Angina; Coronary disease; Mortality; Quality of life; Revascularisation

Indexed keywords

ANTIANGINA PECTORIS AGENT;

AGED; ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DATA ANALYSIS; DEATH; ELDERLY CARE; FEMALE; HAZARD ASSESSMENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURGICAL PATIENT; TREATMENT OUTCOME; WELLBEING;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3042798034     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.02.033     Document Type: Article

References (23)

1. Gersh B.J., Kronmal R.A., Schaff H.V., et al. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older: a nonrandomized study from the Coronary Artery Surgery Study (CASS) Registry. N. Engl. J. Med. 313:1985;217-224
2. Nasser T.K., Fry E.T.A., Annan K., et al. Comparison of six-month outcome of coronary artery stenting in patients. < 65, 65-75, and > 75 years of age Am. J. Cardiol. 80:1997;998-1001
3. Alexander K.P., Anstrom K.J., Muhlbaier L.H., et al. Outcomes of cardiac surgery in patients age ≥80 years: results from the National Cardiovascular Network. J. Am. Coll. Cardiol. 35:2000;731-738
4. De Gregorio J., Kobayashi Y., Albiero R., et al. Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. J. Am. Coll. Cardiol. 32:1998;577-583
5. Wennberg D.E., Malenka D.J., Sengupta A., et al. Percutaneous transluminal angioplasty in the elderly: epidemiology, clinical risk factors, and in-hospital outcomes. Am. Heart J. 137:1999;639-645
6. Batchelor W.B., Anstrom K.J., Muhlbaier L.H., et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7472 octogenarians. J. Am. Coll. Cardiol. 36:2000;723-730
7. Lee P.Y., Alexander K.P., Hammill B.G., et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 286:2001;708-713
8. The TIME Investigators: Trial of Invasive versus Medical therapy in Elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomized trial. Lancet 2001;358:951-57
9. Pfisterer M., Buser P., Osswald S., et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs. optimized Medical Treatment Strategy. One-year results of the randomized TIME trial. JAMA. 289:2003;1117-1123
10. Bullinger M. German translation and psychometric testing of the SF-36 health survey: preliminary results from the IQOLA project. Soc. Sci. Med. 4:1995;1359-1366
11. Hlatky M.A., Boineau R.E., Higginbotham M.B., et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am. J. Cardiol. 64:1989;651-654
12. Rose G.A., Blackburn H., Gillum R.F., et al. Cardiovascular survey methods. 2nd ed. World Health Organization monograph series. 56:1982;World Health Organization, Geneva
13. Aldermann E.L., Bourassa M.G., Cohen L.S., et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 82:1990;1629-1646
14. European Coronary Surgery Study Group. Long-term results of a prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982;2:1173-80
15. The VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation 1992;86:121-30
16. Strauss W.E., Fortin T., Hartigan P., et al. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Outcomes of a randomized clinical trial. Veterans Affairs Study of Angioplasty Compared to Medical Therapy Investigators. Circulation. 92:1995;1710-1719
17. RITA-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: the second Randomized Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-8
18. Pitt B., Waters D., Brown W.V., et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N. Engl. J. Med. 341:1999;70-76
19. Kähler J., Lütke M., Weckmüller, et al. Coronary angioplasty in octogenarians. Quality of life and costs. Eur. Heart J. 20:1999;1791-1798
20. Graham M.M., Ghali W.A., Faris P.D., et al. Survival after coronary revascularization in the elderly. Circulation. 105:2002;2378-2384
21. Rihal C.S., Gersh B.J., Yusuf S. Chronic coronary artery disease: coronary artery bypass surgery versus percutaneous transluminal coronary angioplasty versus medical therapy. Yusuf S., Cairns J.A., Camm A.J., et al. Evidence based cardiology. 1999;368-392 JB BMJ Books, London
22. Morice M.-.C., Serruys P.W., Sousa J., et al. Revascularization with a Sirolimus-eluting versus an uncoated stent in patients with coronary artery disease. N. Engl. J. Med. 346:2002;1773-1780
23. Kloeter U.C.D., Jander N.G., Buser P.T., et al. Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization. Int. J. Cardiol. 79:2001;197-205